98 related articles for article (PubMed ID: 21418865)
1. [Association between side effects of oral anti-diabetic drugs and self-reported mental health and quality of life among patients with type 2 diabetes].
Chen ZC; Zhang SL; Yan L; Wu MC; Chen LH; Ji LN
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):229-33. PubMed ID: 21418865
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific region.
Sheu WH; Ji LN; Nitiyanant W; Baik SH; Yin D; Mavros P; Chan SP
Diabetes Res Clin Pract; 2012 May; 96(2):141-8. PubMed ID: 22265956
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
Vexiau P; Mavros P; Krishnarajah G; Lyu R; Yin D
Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():16-24. PubMed ID: 18435670
[TBL] [Abstract][Full Text] [Related]
4. Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus.
Green AJ; Fox KM; Grandy S;
Diabetes Res Clin Pract; 2012 Jun; 96(3):313-8. PubMed ID: 22296853
[TBL] [Abstract][Full Text] [Related]
5. Self-reported experience of hypoglycemia among adults with type 2 diabetes mellitus (Exhype).
Pettersson B; Rosenqvist U; Deleskog A; Journath G; Wändell P
Diabetes Res Clin Pract; 2011 Apr; 92(1):19-25. PubMed ID: 21195501
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life.
Pollack MF; Purayidathil FW; Bolge SC; Williams SA
Diabetes Res Clin Pract; 2010 Feb; 87(2):204-10. PubMed ID: 20036433
[TBL] [Abstract][Full Text] [Related]
7. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients.
Williams SA; Shi L; Brenneman SK; Johnson JC; Wegner JC; Fonseca V
J Diabetes Complications; 2012; 26(5):399-406. PubMed ID: 22699113
[TBL] [Abstract][Full Text] [Related]
8. Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea.
Lund A; Knop FK
Curr Med Res Opin; 2012 May; 28(5):731-6. PubMed ID: 22462528
[TBL] [Abstract][Full Text] [Related]
9. Impact of Hypoglycemia on Health-Related Quality of Life among Type 2 Diabetes: A Cross-Sectional Study in Thailand.
Pratipanawatr T; Satirapoj B; Ongphiphadhanakul B; Suwanwalaikorn S; Nitiyanant W
J Diabetes Res; 2019; 2019():5903820. PubMed ID: 31772942
[TBL] [Abstract][Full Text] [Related]
10. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
[TBL] [Abstract][Full Text] [Related]
11. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes.
Florez H; Luo J; Castillo-Florez S; Mitsi G; Hanna J; Tamariz L; Palacio A; Nagendran S; Hagan M
Postgrad Med; 2010 Mar; 122(2):112-20. PubMed ID: 20203462
[TBL] [Abstract][Full Text] [Related]
12. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
[TBL] [Abstract][Full Text] [Related]
13. The economic and quality of life impact of hypoglycemia.
Lundkvist J; Berne C; Bolinder B; Jönsson L
Eur J Health Econ; 2005 Sep; 6(3):197-202. PubMed ID: 15761775
[TBL] [Abstract][Full Text] [Related]
14. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain.
Marrett E; Stargardt T; Mavros P; Alexander CM
Diabetes Obes Metab; 2009 Dec; 11(12):1138-44. PubMed ID: 19758360
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported impact of urinary incontinence--results from treatment seeking women in 14 European countries.
Monz B; Pons ME; Hampel C; Hunskaar S; Quail D; Samsioe G; Sykes D; Wagg A; Papanicolaou S
Maturitas; 2005 Nov; 52 Suppl 2():S24-34. PubMed ID: 16297579
[TBL] [Abstract][Full Text] [Related]
17. Effects of the diabetic patients' perceived social support on their quality-of-life.
Göz F; Karaoz S; Goz M; Ekiz S; Cetin I
J Clin Nurs; 2007 Jul; 16(7):1353-60. PubMed ID: 17584354
[TBL] [Abstract][Full Text] [Related]
18. Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetes.
Vinik AI; Zhang Q
Diabetes Care; 2007 Apr; 30(4):795-800. PubMed ID: 17259481
[TBL] [Abstract][Full Text] [Related]
19. How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey.
Mosnier-Pudar H; Hochberg G; Eschwege E; Virally ML; Halimi S; Guillausseau PJ; Peixoto O; Touboul C; Dubois C; Dejager S
Diabetes Metab; 2009 Jun; 35(3):220-7. PubMed ID: 19303338
[TBL] [Abstract][Full Text] [Related]
20. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
Grossman LD; Parlan G; Bailey AL; Yee G; Yu M; Chan JY
Clin Ther; 2009 Jan; 31(1):74-88. PubMed ID: 19243708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
